The name Johns Hopkins has become synonymous with excellence in research and patient care.  Its science and medical programs earn more federal research dollars than any other medical institution in the country.

Since its opening in 1973, our Cancer Center has led the world in deciphering the mechanisms of cancer and new ways to treat it.  The strength of our research and treatment programs was recognized early on by the National Cancer Institute, becoming one of the first to earn comprehensive cancer center status and recognition as a “Center of Excellence.”

One of only 40 cancer centers in the country designated by the National Cancer Institute (NCI) as a Comprehensive Cancer Center, the Johns Hopkins Kimmel Cancer Center has active programs in clinical research, laboratory research, education, community outreach, and prevention and control. The Kimmel Cancer Center is the only Comprehensive Cancer Center in the state of Maryland.For more information click here.

Malcolm V. Brock, MD, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

Dr. Brock’s research has focused primarily on developing and clinically applying molecular biomarkers, namely DNA methylation, to facilitate the early detection, accurate prognosis and specific chemosensitivity of lung and esophageal cancers. Current projects include using DNA methylation as a more … read more ❯

Phillip A. Dennis, MD, Ph.D, at Sidney Kimmel Comprehensive Cancer at Johns Hopkins

Department Affiliation: Primary: Oncology; Secondary: Pharmacology and Molecular Sciences; Degree: M.D., Ph.D., New York University School of Medicine Rank: Professor Chair, Department of Oncology, Johns Hopkins Bayview Medical Center Director, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Bay … read more ❯